Androgenetic alopecia (AGA) management is a significant clinical and therapeutic challenge for transgender and gender diverse (TGD) patients. Although gender-affirming hormone therapies affect hair growth, there is little research about AGA in TGD populations. After reviewing the literature on approved…

• As with many other cancers, the neutrophil-to-lymphocyte ratio reflects the disease activity in cutaneous squamous cell carcinoma. • Examination of the neutrophil-to-lymphocyte ratio before treatment can allow an assessment of the disease activity, which may help in the risk…

BRAF-inhibitors have emerged as a promising targeted therapy for malignancies with BRAF mutations, particularly metastatic melanoma. However, granulomatous reactions including sarcoidosis and sarcoid-like-reactions have been reported as a consequence of BRAF-inhibition. It is important to adequately characterise these granulomatous reactions…

• Although topical corticosteroids and calcineurin inhibitors are somewhat effective, safety concerns exist regarding their treatment of atopic dermatitis (AD). • This phase 3 trial demonstrates that difamilast, a phosphodiesterase 4 inhibitor, is an effective and well tolerated treatment option…